News

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...
Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...
We’ve uncovered a list of what we consider to be five recession-proof dividend stocks yielding over 6%, much higher than the ...
Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...
Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...
That said, Pfizer Inc. (NYSE:PFE) has a five-year average payout ratio above 101%, which may seem alarming at first. A company can’t consistently pay more in dividends than it earns.
Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks ...
The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...
Barron’s has long favored dividend-paying stocks for those seeking income. But bonds now deserve a hard look because they are ...
The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...
For this list, we're looking at U.S. stocks only that trade on major exchanges, with market caps of at least $10 billion. The ...
There is perhaps no better way to put a $500,000 windfall to work than to stash it in a self-directed investment portfolio.